ABSTRACT
INTRODUCTION
Poliomyelitis is a disease of great antiquity. Perhaps the earliest description is evident in an Egyptian stele from around 1350 BC depicting a young man with typical asymmetric flaccid paralysis and atrophy of the leg. Several reports of the disease also appeared in the literature from the 17 th and 18 th centuries. By the mid 19 th century, the industrial revolution had brought increased urbanization to Europe and North America, changes and improvements in living conditions. Coincident with these massive changes was the advent of larger and more frequent outbreaks of poliomyelitis. From the late 1800s, outbreaks were occurring in several European countries and in the United States (1) . Poliomyelitis was established as a viral disease in 1909 when Landsteiner and proper transmitted paralytic disease to monkeys by inoculating them with filtered stool from a patient with paralytic disease (2) . The major breakthrough for diagnosis and controlling poliomyelitis was the observation that poliovirus could be propagated in human embryonic tissues in culture (3) .
These tissue cultures allowed easy isolation of the viruses and were prerequisite for the development of vaccines, including both the inactivated vaccine of Salk and the attenuated (oral) vaccine of Sabin (2) . The genus Enterovirus is one of four genera belonging to the family Picornaviridae (small ribonucleic acid (RNA) viruses). The enteroviruses, grouped together and named in 1957, acquired their names since they infect the gastrointestinal tract. The genus enterovirus includes poliovirus (three serotypes), coxsackie A virus (23 serotypes including echovirus type 22), coxsackie B virus (six serotypes), echovirus (31 serotypes), and the human enteroviruses 68-71 (4) . Enteroviruses are small RNA viruses consisting of a spherical, nonenveloped protein shell which encapsidate one molecule of singlestranded positive-sense RNA. The poliovirus particle has a diameter of 27 to 30 nm. The virus capsid has an icosahedral symmetry and consists of 60 protomers. Each protomer comprises the four non-glycosylated virus proteins VP1 (34 kDa), VP2 (30kDa), VP3 (27kDa), and VP4 (7.5kDa). The virus proteins VP1, VP2 and VP3 are located at the capsid surface, whereas VP4 is located in the interior of the capsid in close contact with the viral RNA.
It has three antigenic types (serotypes 1, 2, and 3) whose physical properties are nearly identical. The different serotypes share between 36 and 52% of their nucleotide sequences. Neutralizing antibodies are directed towards VP1, VP2, and VP3, present in copies of 60 each of VP1 and VP3 and 58 to 59 copies of VP2 and VP4, containing at least four epitopes located on the surface of the virion. VP1 is the immuno-dominant antigen (5) .
Aim of the work
Paralytic poliomyelitis continues to be important disease affecting many children. The strategy for poliomyelitis eradication includes routine immunization, surveillance of acute flaccid paralysis (AFP) and mopping-up activities. Environmental monitoring, mainly involving the screening of waste water can provide evidence of the circulation or absence of wild-type polioviruses. The ultimate goal of the polio eradication initiative is to stop polio vaccination. This can be only achieved by ensuring cessation of circulation of vaccine derived poliovirus (VDPVs), which were found to cause outbreaks of paralytic polio. 
MATERIALS & METHODS

Study population:
Virus strains used in the current study was isolated from 38 stool specimens collected from children suffering from AFP cases from 
b. 2-RT-PCR for intratypic differentiation (7)
Reverse transcription-PCR was performed on identified typed polioviruses. The viral RNA was released by heat and converted to complementary deoxyribonucleic acid (cDNA) using reverse transcriptase. The cDNA was amplified in a conventional PCR reaction using Taq polymerase. The PCR products were resolved by gel electrophoresis to determine size and function as confirmation of product authenticity. Both the cDNA synthesis and the PCR reaction use multiple sets of oligonucleotide primers with different specificities. Primers include Sabin type specific for each of the three serotypes and primers that amplify all polioviruses and all isolates of each of the three serotypes. Such combination of primers will result in characterization of polio isolates and will also confirm the serotype identification of the isolate.
RESULTS
Demographic characteristics of the study population:
The age ranged from 4 months to 14 years with a mean of 2.28±2.29 years. They were 24 boys (58.53%) and 17 girls (41.46%), the male to female ratio was 1.5: 1.06.
Geographical distribution:
Poliovirus was detected in 21 cases (51.21%) from Fayoum, Benisuef, Menya, Souhag, Assuit and Kena (Upper Egypt), in 14 cases (34.14%) from Behira, Kalyoubia, Menoufia, Dakahlia, Alexandria, Sharkia and Kafr El-Sheikh (Lower Egypt) and in 6 cases (14.63%) from Cairo and Giza (Greater Cairo) (figure 1).
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Figure (1): Geographical distribution of poliovirus in Egypt
Prevalence of isolation of each serotype post vaccination:
PV3 was isolated from 11 cases within group 1 (37.93%), PV1 was isolated from 12 cases (41.38%), PV2 was isolated from 3 cases (10.34%) and mixture of PV2 and PV3 was isolated from 2 cases (6.9%). One case (3.45%) developed AFP post vaccination with no virus shedding.
Virus identification:
Virus isolation and identification using specific antisera revealed that 18 (43.90%) of cases were poliovirus type 1; 5 cases (12.2%) were poliovirus type 2 and 14 cases (34.15%) were poliovirus type 3. mixture of poliovirus type 2 and poliovirus type 3 was found in 3 cases (7.32%). Intratypic differentiation was done by two different methods: 1. Antigenic method (ELISA) and isolates were characterized as: Eighteen cases were poliovirus type 1:  9 out 18 (50%) were non Sabin poliovirus type 1 (NSL1).  9 out 18 (50%) was Sabin like poliovirus type 1 (SL1).  5 cases were Sabin like (SL) poliovirus type 2, 14 cases were SL poliovirus type 3 and 3 cases were SL2 and SL3.
RT-PCR:
 Poliovirus strains were subjected to RT-PCR with pan poliovirus primer specific bands of 79 bp were detected ( fig. 2)  18 isolates were positive using PV serotype 1 primer  5 isolates were positive using PV serotype 2 primer  14 isolates were positive using PV serotype 3 primer  With multiplex primer, 8 isolates were SL1, 5 isolates were SL2, 14 isolates were SL3 and 3 isolates were a mixture of SL2 and SL3. 
Sequencing of amplified product
Analysis of the sequencing of the VP1/2A region (295bp) has been performed on 22 available isolates and showed that 4 isolates were SL1, 3 isolates were SL2, 6 isolates were SL3 and 9 isolates were wild poliovirus type 1. 
DISCUSSION
Paralytic poliomyelitis has been known for at least 3500 years and continues to be serious threat to children in parts of Asia, Africa and the Middle East. Poliovirus infects and replicates in the intestinal tract. Over 90% of infections are unapparent, but a viremia can develop and cause AFP usually 7-14 days after infection. The site of the paralysis depends on the location of the nerve cells destruction. The paralysis is typically asymmetric and reaches its maximum extent within 3-4 days. Any paralysis still present after 60 days is likely to be permanent. Humans are the only reservoir of poliovirus and infection is transmitted by the oralfecal route and less commonly by pharyngeal secretion The third outbreak occurred in Angola, which had been polio-free since 200l, with 2 reported polio cases. Genetic sequencing shows that it originated in India, epidemiological evidence suggests a recent importation
Despite the many advantages of OPV, the most serious complication of its use is Vaccine associated paralytic poliomyelitis (VAPP) which is associated with reversion of the attenuated virus to its neurovirulent form (16) . Compared with immunocompetent children, the risk of VAPP is almost 7,000 times higher for persons with certain types of immunodeficiencies, particularly B lymphocyte disorders (e.g., agammaglobulinemia and hypogamma-globulinemia).
The risk of VAPP was not equal for all OPV doses in the vaccination series. The risk of VAPP is 7 to 2l times higher for the first dose than for any other dose in the OPV series. . These molecular methods are based on the rapid evolution of the poliovirus genome during replication in the human gut. An estimated 1 to 2% of the total genome changes per year at a rate of 1-2 fixed nucleotide substitutions per week.
Most nucleotide substitutions are silent mutations, not causing changes in amino acid composition. The estimation of an epidemiologic link is based on this rapid evolution of poliovirus genomes by study of the patterns of nucleotide variation (10)
In our study, poliovirus was isolated from 39 cases suffering from AFP and two contact cases. Our goals of the present study were to identify sequence divergence or neurovirulent derivatives of the Sabin OPV strains, to establish epidemiological link between isolates, and to determine poliovirus genotype which circulate in Egypt. Comparing the geographical distribution of polioviruses, 51.21% of cases were from Upper Egypt, 34.14% of cases were from lower Egypt and 14.63% were from Greater Cairo. All patients had received OPV and were classified as having VAPP according to WHO classification criteria (23) . OPV derived strains were isolated from 31 cases (75.61%) who presented a poliomyelitis syndrome with AFP, while wild poliovirus was detected in 9 cases (21.95) and no virus was isolated from one case (2.44%).
Our findings reveal that the incidence of AFP cases post vaccination due to type 1 was 41.38%, type 2 was 10.34%, type three was 37.93%, mixture of type 2 and type 3 was 6.90% and one (3.45%) developed AFP post vaccination with no virus shedding. Study done by Strebel et al. (24) , showed that the incidence of VAPP cases due to type 1 vaccine derived poliovirus is significantly lower than that for type 3 or type 2 virus, suggesting that the type 1 vaccine strain has the most stable attenuated phenotype.
In our study, patient number 14 stopped poliovirus shedding after 12 weeks, while patient number 41 excreted the virus for 9 weeks. No nucleotide difference was obtained when sequential samples of case number 14 and case number 41 were analyzed. Study done by Triki et al., on the duration of poliovirus excretion showed that virus was excreted during at least 7 weeks (25) , while study by Alexander et al. (26) , showed that fecal excretion of vaccine viruses continues beyond the fifth week in less than 20% of immunized individuals Intratypic differentiation using both the antigenic ELISA method and the molecular PCR method revealed that Sabin 3 was isolated from 34. 
